Mogling Bio
Latest round
- Seed
Last raised
- Oct 2022
Total raised
- Undisclosed
Investors
- 1
About Mogling Bio
Based in Delaware, US, Mogling Bio treats old blood cell formation systems to rejuvenate in a pharmacological way. The company was co-founded by Jurgen Reeb, Yi Zheng, and Hartmut Geiger. The company develops new pharmacological approaches which help in rejuvenating old stem cells of the hematopoietic (blood cell formation) system. It helps in normalizing CDC42 activity as well as restoring structure, order, and functionality in aged stem cells. The firm approaches contribute to both, the rejuvenation of stem cells and the immune system.
Who invested in Mogling Bio
1 investor across 1 round
See all investors in Mogling Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 26, 2022
Amount
Undisclosed
Investors
Questions about Mogling Bio
Who invested in Mogling Bio?
Mogling Bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mogling Bio raised?
Mogling Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mogling Bio last raise money?
Mogling Bio's most recent round on record is a Seed, in Oct 2022.
What does Mogling Bio do?
Based in Delaware, US, Mogling Bio treats old blood cell formation systems to rejuvenate in a pharmacological way.
Where is Mogling Bio headquartered?
Mogling Bio is headquartered in Wilmington, US.
Which VCs invest in companies like Mogling Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Mogling Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Mogling Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.